BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 1068340)

  • 1. L-asparaginase reinduction and maintenance therapy in previously treated acute lymphocytic leukemia.
    Sieger L; Higgins G; Ortega J; Shore N; Williams K
    Med Pediatr Oncol; 1976; 2(3):327-32. PubMed ID: 1068340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. L-Asparaginase as a single agent in acute lymphocytic leukemia: survey of studies form Childrens Cancer Study Group.
    Nesbit ME; Ertel I; Hammond GD
    Cancer Treat Rep; 1981; 65 Suppl 4():101-7. PubMed ID: 7049373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-Asparaginase, vincristine, and prednisone for induction of first remission in acute lymphocytic leukemia.
    Ortega JA; Nesbit ME; Donaldson MH; Hittle RE; Weiner J; Karon M; Hammond D
    Cancer Res; 1977 Feb; 37(2):535-40. PubMed ID: 264412
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effective dose of L-asparaginase for induction of remission in previously treated children with acute lymphocytic leukemia: a report from Childrens Cancer Study Group.
    Ertel IJ; Nesbit ME; Hammond D; Weiner J; Sather H
    Cancer Res; 1979 Oct; 39(10):3893-6. PubMed ID: 383278
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of intramuscular versus intravenous administration of L-asparaginase in childhood leukemia.
    Nesbit M; Chard R; Evans A; Karon M; Hammond GD
    Am J Pediatr Hematol Oncol; 1979; 1(1):9-13. PubMed ID: 295576
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of acute lymphoblastic leukemia in relapse: efficacy of a four-drug reinduction regimen.
    Poplack DG; Reaman GH; Wesley R
    Cancer Treat Rep; 1981; 65 Suppl 4():93-6. PubMed ID: 6955015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination chemotherapy for children with acute lymphocytic leukemia who fail to respond to standard remission-induction therapy.
    Lay HN; Ekert H; Colebatch JH
    Cancer; 1975 Oct; 36(4):1220-2. PubMed ID: 1058044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. L-asparaginase used with cytosine arabinoside in treatment of childhood acute lymphocytic leukemia refractory to vincristine and prednisone.
    Smithson WA; Gilchrist GS; Burgert EO
    Med Pediatr Oncol; 1979; 6(2):163-70. PubMed ID: 287856
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sequential combination of methotrexate and L-asparaginase in the treatment of refractory acute leukemia.
    Amadori S; Tribalto M; Pacilli L; De Laurentis C; Papa G; Mandelli F
    Cancer Treat Rep; 1980; 64(8-9):939-42. PubMed ID: 6934851
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Optimal use of L-asparaginase (NSC-109229) in acute lymphocytic leukemia.
    Jones B; Holland JF; Glidewell O; Jacquillat C; Weil M; Pochedly C; Sinks L; Chevalier L; Maurer HM; Koch K; Falkson G; Patterson R; Seligman B; Sartorius J; Kung F; Haurani F; Stuart M; Burgert EO; Ruymann F; Sawitsky A; Forman E; Pluess H; Truman J; Hakami N
    Med Pediatr Oncol; 1977; 3(4):387-400. PubMed ID: 337095
    [No Abstract]   [Full Text] [Related]  

  • 11. [L-asparaginase in combined treatment of acute leukemia not affecting the bone marrow].
    Cyklis R; Armata J; Legutko L
    Acta Haematol Pol; 1974; 5(3):201-6. PubMed ID: 4528224
    [No Abstract]   [Full Text] [Related]  

  • 12. Comparison of the therapeutic response of patients with childhood acute lymphoblastic leukemia in relapse to vindesine versus vincristine in combination with prednisone and L-asparaginase: a phase III trial.
    Anderson J; Krivit W; Chilcote R; Pyesmany A; Chard R; Hammond D
    Cancer Treat Rep; 1981; 65(11-12):1015-9. PubMed ID: 6945911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. E. coli L-asparaginase in the treatment of leukemia and solid tumors in 131 children.
    Tallal L; Tan C; Oettgen H; Wollner N; McCarthy M; Helson L; Burchenal J; Karnofsky D; Murphy ML
    Cancer; 1970 Feb; 25(2):306-20. PubMed ID: 4905155
    [No Abstract]   [Full Text] [Related]  

  • 14. Asparaginase in combination chemotherapy for remission induction of childhood acute lymphocytic leukemia.
    Pratt CB; Roberts D; Shanks E; Warmath EL; Jackson R
    Cancer Res; 1973 Sep; 33(9):2020-5. PubMed ID: 4516498
    [No Abstract]   [Full Text] [Related]  

  • 15. Reduced antithrombin III levels during L-asparaginase therapy.
    Buchanan GR; Holtkamp CA
    Med Pediatr Oncol; 1980; 8(1):7-14. PubMed ID: 6934369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [L-Asparaginase therapy in chemotherapy-resistant acute lymphocytic leukemias (author's transl)].
    Kawashima K; Morishima Y; Kato Y; Suzuki H; Takeyama H; Kobayashi M; Watanabe E; Esaki K; Ogata K; Takamatsu J; Minami S; Yamada K; Naito K; Yoshikawa S; Ogura M; Morishita T; Nishiwaki H; Kawai M; Sako F; Kawabe M; Yamada H
    Rinsho Ketsueki; 1979 Apr; 20(4):355-63. PubMed ID: 286816
    [No Abstract]   [Full Text] [Related]  

  • 17. Comparison of daily and twice-weekly schedule of L-asparaginase in childhood leukemia.
    Jaffe N; Traggis D; Das L; Kim BS; Won H; Hann L; Moloney WC; Dohlwitz A
    Pediatrics; 1972 Apr; 49(4):590-5. PubMed ID: 4501679
    [No Abstract]   [Full Text] [Related]  

  • 18. Combination chemotherapy for bone marrow relapse in childhood lymphoblastic leukaemia (ALL).
    Chessells JM; Cornbleet M
    Med Pediatr Oncol; 1979; 6(4):359-65. PubMed ID: 289904
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of protracted high-dose L-asparaginase given as a second exposure in a Berlin-Frankfurt-Münster-based treatment: results of the randomized 9102 intermediate-risk childhood acute lymphoblastic leukemia study--a report from the Associazione Italiana Ematologia Oncologia Pediatrica.
    Rizzari C; Valsecchi MG; Aricò M; Conter V; Testi A; Barisone E; Casale F; Lo Nigro L; Rondelli R; Basso G; Santoro N; Masera G;
    J Clin Oncol; 2001 Mar; 19(5):1297-303. PubMed ID: 11230471
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Repeated treatment with L-asparaginase of acute lymphoblastic leukemia in children].
    Zajaczkowski J; Depowska T; Legutko L; Armata J
    Pol Tyg Lek; 1974 Aug; 29(32):1381-3. PubMed ID: 4527522
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.